Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accumulated Depreciation (2023 - 2025)

Upstream Bio (UPB) has 3 years of Accumulated Depreciation data on record, last reported at $287000.0 in Q3 2025.

  • For Q3 2025, Accumulated Depreciation changed N/A year-over-year to $287000.0; the TTM value through Sep 2025 reached $287000.0, changed N/A, while the annual FY2024 figure was $156000.0, 132.84% up from the prior year.
  • Accumulated Depreciation reached $287000.0 in Q3 2025 per UPB's latest filing, up from $241000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $287000.0 in Q3 2025 and bottomed at $67000.0 in Q4 2023.
  • Average Accumulated Depreciation over 3 years is $190000.0, with a median of $199000.0 recorded in 2025.
  • The widest YoY moves for Accumulated Depreciation: up 132.84% in 2024, down 132.84% in 2024.
  • A 3-year view of Accumulated Depreciation shows it stood at $67000.0 in 2023, then surged by 132.84% to $156000.0 in 2024, then skyrocketed by 83.97% to $287000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation were $287000.0 in Q3 2025, $241000.0 in Q2 2025, and $199000.0 in Q1 2025.